| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.05 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.056 | 0.05 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.05 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.082 | 0.06 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.06 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.06 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.098 | 0.06 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.06 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.084 | 0.06 |